The U.S. District Court for the District of New Jersey ruled Lilly's method-of-usepatent for Strattera, which had been set to expire in 2017, was invalid.
They require patent applicants to declare any use of hereditary material obtained from humans, animals, plants or microbes if inventions are dependent on those genetic resources.
如果发明中利用了基因资源,专利申请人必须申明其所使用的所有从人、动植物或微生物中获取的遗传物质。
3
The site has been asked to detail a "statement of use" by the US Patent and Trademark Office, explaining how it intends to use the word.